Search database
Filter
4521
Text search: drug policy
Featured
Language
Document type
2858
662
504
172
151
56
45
44
11
8
5
4
1
Countries
215
155
130
115
112
108
105
104
92
82
79
78
75
74
72
68
64
61
61
59
54
52
49
41
40
36
35
35
34
33
32
28
22
21
21
20
19
18
15
15
13
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
7
7
7
7
6
6
6
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
531
294
250
186
145
110
91
76
60
41
38
34
29
28
27
24
24
23
22
22
21
20
19
19
19
19
18
18
18
17
17
17
16
16
15
14
14
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1825
371
230
170
79
51
49
1
1
Toolboxes
597
503
412
246
166
137
91
87
78
68
59
58
55
53
51
46
31
23
16
13
9
8
6
1
 Download
  View PDF
 Add to my MEDBOX

Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies. (Russian version)

World Health Organization Всемирная организация здравоохранения (2017) C_WHO
Aлгоритм лабораторной диагностики и мониторинга лечения туберкулеза легких и туберкулеза с лекарственной устойчивостью на основе применения современных быстрых ... more
 Download
  View PDF
 Add to my MEDBOX

Lesotho correctional service HIV and AIDS policy

National AIDS Commission (NAC) and Lesotho Correctional Services (LCS), Government of Lesotho (2009) C2
 Download
  View PDF
 Add to my MEDBOX

Global action plan on HIV drug resistance 2017–2021

World Health Organization (WHO) (2017) C_WHO
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ... more
 Download
  View PDF
 Add to my MEDBOX

Approaches for mobile and migrant populations in the context of malaria multi-drug resistance and malaria elimination in the Greater Mekong Subregion

World Health Organization ( WHO), Regional Office for South-East-Asia (2016) C_WHO
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (‎GMS)‎ has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response, ... more
 Download
  View PDF
 Add to my MEDBOX

National Guidelines and Operational Manual for Programmatic Management of Drug Resistant TB (PMDT), 2nd ed.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services (2013) C1
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... more
 Download
  View PDF
 Add to my MEDBOX

Field Guide for the Management of Drug-Resistant Tuberculosis
recommended

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
 Download
  View PDF
 Add to my MEDBOX

Expansion Plan of Programmatic Management of Drug Resistant TB (PMDT)

National TB Control Programme, Bangladesh World Health Organization WHO, Bangladesh (2013) C1
 Download
  View PDF
 Add to my MEDBOX

Child and adolescent Mental health in europe: infrastructures, policy and programmes

F. Braddick; V. Carral; R. Jenkins; E. Jané-Llopis European Commission; Generalitat de Catalunya Department de Salud; Institute of Psychiatry; Kings College London; State Mental Health Center ; et al. (2009) C2
CAMHEE
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections. Summary of recommendations and key messages

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
 Download
  View PDF
 Add to my MEDBOX

Women’s Mental Health: Promoting a Gendered Approach to Policy and Service Provision

The Women´s Health Council The Women´s Health Council (2007) CC
The mission of the Women’s Health Council is to inform and influence the development of health policy to ensure the maximum health and social gain for women in Ireland. Its membership is representative of a wide range of expertise and interest i ... more
 Download
  View PDF
 Add to my MEDBOX

Preventing and responding to HIV drug resistance in the african region

World Health Organization WHO (Africa) World Health Organization WHO (Africa) (2019) C_WHO
Regional action plan 2019-2023
 Download
  View PDF
 Add to my MEDBOX

Public health dimension of the world drug problem

World Health Organization WHO (2022) C_WHO
Report by the Director-General. 75th World health assembly 25 April 2022
 Download
  View PDF
 Add to my MEDBOX

Involving Persons Living with HIV Networks in National HIV Policy Dialogue A Case Study of MANET+ in Malawi

M. L. Mattingly; A. G. Yemaneberhan; S. Feller; et al. USAID; PEPFAR; AIDS Free (Strenghtening High Impact Interventions for a AIDS-free Generation); JSI Research & Training Institute; et al. (2016) C2
AIDSFree Case study series This publication is made possible by the generous support of the American people through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID) under the terms of Cooperative Agreement AID-OAA-A-14-00046 ... more
 Download
  View PDF
 Add to my MEDBOX

An Advocacy Strategy for Adoption and Dissemination of the WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Household

D’A. Richardson; G. Pirio; et al. USAID; Stop TB Partnership; TB online (2010) C2
Recommended actions at international and national levels
 Download
  View PDF
 Add to my MEDBOX

Fast-tracking HIV treatment: Parliamentary action and policy options

P. Bayr; L. Davies; F. Ndugulile; et al. Inter-Parliamentary Union (For democracy, For everyone); UNAIDS (2015) C2
 Download
  View PDF
 Add to my MEDBOX

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment,update

World Health Organization WHO (2022) C_WHO
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on ... more
 Download
  View PDF
 Add to my MEDBOX

Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement

World Health Organization WHO (2022) C_WHO
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij ... more
 Download
  View PDF
 Add to my MEDBOX

Kenya National Infection Prevention and Control Policy for Health Care Services, Third Edition

Ministry of Health (2021) CC
The Government of Kenya, through the Ministry of Health, has the constitutional obligation to provide the highest level of health care for its citizens. The Ministry of Health’s review of the 2015 Policy document on infection prevention and con ... more
 Download
  View PDF
 Add to my MEDBOX

Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians

World Health Organization WHO (2022) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Strategy to respond to antimalarial drug resistance in Africa

World Health Organization WHO (2022) C_WHO
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial ... more
 External Link
 Add to my MEDBOX

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries

Torres-Rueda S.; S. Sweeney; F. Bozzani et al. BMJ Global Health (2021) C2
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di ... more
 Add to my MEDBOX

Multiple first-line therapies as part of the response to antimalarial drug resistance

World Health Organization WHO (2024) C_WHO
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... more
 Download
  View PDF
 Add to my MEDBOX

Role of sterile injection equipment and outreach programmes for injecting drug users

World Health Organization (2012) C_WHO
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode ... more
 Download
  View PDF
 Add to my MEDBOX

Access to hepatitis C testing and treatment for people who inject drugs and people in prisons – a global perspective. Policy brief

World Health Organization WHO (2019) C_WHO
 Download
  View PDF
 Add to my MEDBOX

National HIV and AIDS , STI Policy

Ghana AIDS Commission (2013) C1
 Download
  View PDF
 Add to my MEDBOX

Updated Guidelines for Prevention of Parent to Child Transmission (PPTCT) of HIV using Multi Drug Anti-retroviral Regimen in India

NACO (2013)
 Download
  View PDF
 Add to my MEDBOX

TIP 18: The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Treatment Providers: Treatment Improvement Protocol (TIP) Series 18

D. H. Mulligan, U.S Department of health and human service (1995) C2
 Download
  View PDF
 Add to my MEDBOX

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis

World Health Organization, Europe (2016) C_WHO
 External Link
 Add to my MEDBOX

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

K.Dheda, T. Gumbo, G. Maartens, et al. The Lancet Respiratory Medicine Commission (2017) C2
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
 Download
  View PDF
 Add to my MEDBOX

Infection prevention, control and surveillance: Limiting the development and spread of drug-resistance

O’Neill, J. Review on Antimicrobial Resistance (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Tanzania HIV/AIDS and Malaria Indicator Survey 2011-12: Policy Briefs

Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF International (2013) C2
 Download
  View PDF
 Add to my MEDBOX

WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis
recommended

World Health Organization WHO (2018) C_WHO
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
 Download
  View PDF
 Add to my MEDBOX

The United Nations Convention on the rights of the child and implications for clinical, practice, policy and research

M. L. Belfer; S. Song IACAPAP (2012) C2
Miscellaneous Chapter J.7
 Download
  View PDF
 Add to my MEDBOX

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe

A. T. Makadzange; M. Higgins-Biddle; B. Chimukangara; et al. PLOS One (2015) CC
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
 Download
  View PDF
 Add to my MEDBOX

Update on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication

WHO (2021) CC
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients w ... more
 External Link
 Add to my MEDBOX

Patient-Planetary Health Co-benefit Prescribing: Emerging Considerations for Health Policy and Health Professional Practice

N. Redverse (2021) C1
 External Link
 Add to my MEDBOX

Strengthening mental health responses to COVID-19 in the Americas: A health policy analysis and recommendations

A. Tausch; Oliveira e Souza, R.; Martinez Viciana, C.; et al. Pan American Health Organization (2021) CC
The COVID-19 pandemic is having a major impact on the mental health of populations in the Americas. Studies show high rates of depression and anxiety, among other psychological symptoms, particularly among women, young people, those with pre-existing mental health conditions, health workers, and p ... more
 Download
  View PDF
 Add to my MEDBOX

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis (Russian edition)

World Health Organization, Europe Всемирная организация здравоохранения (2016) C_WHO
Примеры надлежащей практики в области укрепления систем здравоохранения с целью профилактики и лечения туберкулеза и лекарственно-устойчивого туберкулеза
 Download
  View PDF
 Add to my MEDBOX

The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance

World Health Organization WHO (2016) C_WHO
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines on hepatitis B and C testing. Policy brief

World Health Organization (WHO) (2017) C_WHO
 Add to my MEDBOX

Six Key Factors in Realizing HIV-Related Human Rights in Kenya: Actions for Policy & Lawmakers

Aids Fonds, KELIN (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Improving the quality of care in the public health system in Bangladesh: building on new evidence and current policy levers

Krishna Hort, Valeria de Oliveira Cruz, Murad Sultan World Health Organisation (WHO) (2017) C_WHO
Bangladesh Health Systems in Transition
 Download
  View PDF
 Add to my MEDBOX

TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis

International Council of Nurses (2015) C2
3rd edition.
 Download
  View PDF
 Add to my MEDBOX

Framework for the engagement of all health care providers in the management of drug resistant tuberculosis

World Health Organization (2015) C_WHO
The END TB strategy
 Download
  View PDF
 Add to my MEDBOX

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO
 External Link
 Add to my MEDBOX

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

G. B. Migliori, E. Pontali, G. Sotgiu, et al. International Journal of Molecular Scienes (2017) C2
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
 Download
  View PDF
 Add to my MEDBOX

Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region (2010–2015)

World Health Organization Eastern Mediterranean (2010) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Norms, standards and processes underpinning WHO vector control policy recommendations

World Health Organization WHO WHO (2020) C_WHO
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of ... more
 Download
  View PDF
 Add to my MEDBOX

Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis

World Health Organization WHO (2021) CC
Meeting Report 27-29 October 2020 The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ... more
 Download
  View PDF
 Add to my MEDBOX

Developing and Strengthening Community Health Worker Programs at Scale, A Reference Guide for Program Managers and Policy Makers

USAID, MCHIP (2013) CC
Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them as effective as possible. With this in mind, this manual is ... more
 Download
  View PDF
 Add to my MEDBOX

Cost and Outcomes of ART Scale-up in Zambia: Modelled estimates for test and treat & community based service delivery models. Policy brief

USAID, et al. (2016) C1
 External Link
 Add to my MEDBOX

A review of the role of civil society in advocacy and lobbying for enforcement of health policy in Kenya

P. A. Omungo African Population Studies; ResearchGate (2011) C2
Examen du rôle de la société civile dans le plaidoyer et le lobbying en faveur de l'application de la politique de santé au Kenya African Population Studies Vol 25, 1 (Supplement) 2011 http://aps.journals.ac.za
 Download
  View PDF
 Add to my MEDBOX

South African MATERNAL, PERINATAL, and NEONATAL Health Policy

National Department of Health (NDoH) South Africa NDoH South Africa (2021) CC
As a lower-middle-income country (LMIC), South Africa (SA) bears the burden of maternal and neonatal mortality similar to other sub- Saharan African countries. According to the Saving Mothers Report 2017/19, there has been a progressive and sustained reduction in institutional maternal mortality ... more
 Add to my MEDBOX

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended

World Health Organization WHO (2022) C_WHO
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi ... more
 Add to my MEDBOX

Antimicrobials use, reistance and containment baseline survey (Ethiopia)

Drug Administration and Control Authority of Ethiopia , et al. (2009) C1
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug ... more
 Add to my MEDBOX

List of Medicines for Drug Shop , Ethiopia (LMDS)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2012) C1
Fourth edition
 Add to my MEDBOX

Capacity-Building in Community-Based Drug Treatment Services

Cole, M.J. Health and Human Rights Journal (2022) CC
The article "Capacity-Building in Community-Based Drug Treatment Services" by Michael J. Cole focuses on the global challenges in providing adequate community-based drug treatment services. It highl ... more
 Download
  View PDF
 Add to my MEDBOX

Emergency Drug Guidelines. Fiji

Ministry of Health, Fiji World Health Organization WHO (2008) C_WHO
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guid ... more
 Download
  View PDF
 Add to my MEDBOX

Botswana National Drugs (Medicine) Policy

Ministry of Health, Gabarone, Botswana (2005) C2
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - Part 1

National Drug Authority (NDA), Uganda (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Women speak out: understanding women who inject drugs in Indonesia

Indonesian Drug Users Network (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Unintended Consequences: Drug Policies Fuel the HIV Epidemic in Russia and Ukraine

K. Malinowska-Sempruch; J. Hoover; A. Alexandrova Open Society Institute International Harm Reduction Development; IHRD (International Harm Reduction Development) (2003) C2
 External Link
 Add to my MEDBOX

The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016

GBD 2016 Alcohol and Drug Use Collaborator (2018) CC
a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Published:November 01, 2018DOI:https://doi.org/10.1016/S2215-0366(18)30337-7
 Download
  View PDF
 Add to my MEDBOX

Uganda: Annual Pharmacovigilance Report July 2015 – June 2016

National Drug Authority, Uganda (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Ukraine country overview

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Accessed: 22.03.2019
 Download
  View PDF
 Add to my MEDBOX

Comorbidity of substance use and mental health disorders in Europe

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on drugs
 Download
  View PDF
 Add to my MEDBOX

Quality Manual

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2012) C1
 Download
  View PDF
 Add to my MEDBOX

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
 Download
  View PDF
 Add to my MEDBOX

Ethiopia: Standard Treatment Guidelines for Health Center

Drug Administration and Control Authority of Ethiopia Contents (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Diagnostics Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
 Download
  View PDF
 Add to my MEDBOX

Scaling up policies, interventions, and measurement for stigma-free HIV prevention, care and treatment services

A. Jain; L. Nyblade PEPFAR; USAID; Health Policy Project (2012) C2
Policy July 2012 Working Paper No. 3
 Download
  View PDF
 Add to my MEDBOX

Managing the Pandemic and Its Aftermath: Economies, Jobs, and International Migration in the Age of COVID-19

Migration Policy Institute (2020) C1
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f ... more
 Add to my MEDBOX

Enhancing Pharmacovigilance in Sub‑Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi

Jusot, V.; Chimimba, F.; Dzabala, N. et al. Drug Safety (2020) CC
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV. Objective The objective of this initi ... more
 Download
  View PDF
 Add to my MEDBOX

Moldova country overview

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Accessed: 28.03.2019
 Add to my MEDBOX

Maldives National Action Plan for Containment of Antimicrobial Resistance 2017-2022

Maldives Food and Drug Authority Ministry of Health (2017) C2
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati ... more
 Download
  View PDF
 Add to my MEDBOX

Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release

National Institute on Drug Abuse (2018) C2
Science Spotlight February 14, 2018
 Download
  View PDF
 Add to my MEDBOX

Kosovo* country overview

A. Smajljaj European Monitoring Centre for Drugs and Drug Addiction (2013) C2
A summary of the national drug situation
 External Link
 Add to my MEDBOX

Best Practice Portal
recommended

European Monitoring Centre for Drugs and Drug Addiction (2022) CC
The Best practice portal is designed to help you find practical and reliable information on what works (and what doesn’t) in the areas of prevention, treatment, harm reduction and social reintegration. It will help you identify tried and tested interventions quickly, allocate resources to what's e ... more
 Download
  View PDF
 Add to my MEDBOX

‘Virus Carriers’ and HIV testing: navigating Ukraine’s HIV policies and programming for female sex workers

A. Tokar; J. Osborne; K. Slobodianiuk; et al. BMC Public Health (BioMed Central); Health Research Policy and Systems (2019) CC
Tokar et al. Health Research Policy and Systems (2019) 17:23 https://doi.org/10.1186/s12961-019-0415-4
 Add to my MEDBOX

Facilitator's Training Guide for a Stigma-Free Health Facility

R. Kidd; S. Clay; M. Stockton; et al. USAID From the American People; PEPFAR; Health Policy Project (2015) C2
Policy June 2015 Training Menus, Facilitation Tips, and Participatory Training Modules
 Download
  View PDF
 Add to my MEDBOX

Models for the legal supply of cannabis: recent developments

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspective on drugs
 Download
  View PDF
 Add to my MEDBOX

New heroin-assisted treatment - Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond

J. Strang; T. Groshkova; N. Metrebian European Monitoring Centre for Drugs and Drug Addiction; Publications Office (2019) C2
EMCDDA Insights - 11 Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

EMCDDA Monographs

T. Rhodes; D. Hedrich European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Harm reduction: evidence, impacts and challenges -10-
 Download
  View PDF
 Add to my MEDBOX

Montenegro country overview

J. Sekulić European Monitoring Centre for Drugs and Drug Addiction (2011) C2
A summary of the national drug situation
 Download
  View PDF
 Add to my MEDBOX

North Macedonia

L. Savikj European Monitoring Centre for Drugs and Drug Addiction (2013) C2
A summary of the national drug situation
 External Link
 Add to my MEDBOX

Best practice portal: standards and guidelines
recommended

European Monitoring Centre for Drugs and Drug Addiction (2019) CC
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. T ... more
 Download
  View PDF
 Add to my MEDBOX

Implementation Research in Health – A Practical Guide

David H. Peters, Nhan T. Tran, Taghreed Adam Alliance for Health Policy and Systems Research (AHPSR) and World Health Organization (2013)
This guide is an attempt to redress the deficit in understanding of implementation research and to encourage programme personnel and implementers to take a greater interest in the subject, recognizing that implementation research is in fact an integral part of programme planning and execution, rathe ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products Bangladesh

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Migration, public health and compulsory screening for TB and HIV

R. Coker Institute for Public Policy Research (2003) C2
Asylum and Migration Working Paper 1
 Download
  View PDF
 Add to my MEDBOX

Tuberculosis and Non-Communicable Diseases

World Health Organization; Global TB Programme; Hannah Monica Dias Policy, Strategy and Innovations (2017) C_WHO
END TB Second Meeting of th WHO Global Coordination Mechanism (GCM/NCD) Working Group on the inclusion of NCDs in other programmatic areas. Accessded December 2017
 Download
  View PDF
 Add to my MEDBOX

Quality of Prevention of Mother to Child Transmission (PMTCT) of HIV Services in Public Hospitals of Hadiya Zone, Southern Ethiopia

B. B. Bachore; F. Tafese; F. Gebissa; et al. Health Systems and Policy Research; iMedPub (2018) C2
2018 Vol.5 No.2:73 DOI: 10.21767/2254-9137.100092 Health Systems and Policy Research ISSN 2254-9137
 Add to my MEDBOX

Situation Analysis and Recommendations: Antibiotic Use and Resitance in Mozambique

The Center for Disease Dynamics, Economics & Policy CDDEP (2015) C2
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable ... more
 Download
  View PDF
 Add to my MEDBOX

Changes in Europe’s cannabis resin market

European Monitoring Centre for Drugs and Drug Addiction (2017) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

Strategies to prevent diversion of opioid substitution treatment medications

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

Market Analysis of synthetic drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Amphetamine-type stimulants, new psychoactive substances -4- World Drug Report 2017 Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Country overview: Kyrgyzstan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Country overview: Georgia

J.D. Javakhishvili; L. Sturua; I. Kirtadze; et al. European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Study report interstate comparison on health

Atal Bihari Vajpayee Institute of Good Governance & Policy Analysis (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Trends in heroin use in Europe — what do treatment demand data tell us?

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Analysis Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Market Analysis of plant-based drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Opiates, cocaine, cannabis World Drug Report 2017 -3- Accessed: 14.03.2019